As per clinical report, long-term chronic infection with Helicobacter pylori has 60%-90% potential to cause peptic ulcer, gastritis, and duodenitis. The International Agency for Research on Cancer (IARC) under World Health Organization (WHO) also categorizes H. pylori as groupⅠcarcinogen. HelicotecUT® and HelicotecUT® Plus are designed to support early detection and treatment of H. pylori highly recommended by IARC.